Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Open in API
Filings indexed 958 across all filing types
Latest filing 2015-09-16 Director's Dealing
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2015-09-16 English
PRIMARY DOCUMENT
Director's Dealing
2015-09-16 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a letter from ITUS Corporation to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3. It is correspondence related to a securities registration filing, specifically a request under Rule 461 for the filing to become effective. The document does not contain financial statements, audit information, or detailed report content. It is a regulatory communication related to a capital raising process but is not itself a capital/financing update or a report. Given the nature of the document as correspondence with the SEC about a registration statement effectiveness, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories. The document length is short and it is not a report or announcement of a report publication, so RPA is not appropriate. Therefore, the classification is RNS with high confidence.
2015-09-16 English
PRIMARY DOCUMENT
Director's Dealing
2015-09-14 English
FORM S-3/A
Capital/Financing Update Classification · 95% confidence The document is a Form S-3/A registration statement amendment filed with the SEC, which is a registration statement under the Securities Act of 1933. It is used by companies to register securities for sale to the public, including common stock, preferred stock, warrants, debt securities, and units. The document includes details about the securities to be registered, the registration fee, and the terms of the offering. It is not an annual report, earnings release, or any other financial report but a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed registration information, not just an announcement or a brief notice, so it is not an RPA or RNS. Hence, the correct classification is CAP with high confidence.
2015-09-14 English
Regulatory Filings 2015
Regulatory Filings Classification · 90% confidence The document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. The length is 15,000 characters, which is substantial, but the content is not interpretable as a financial or corporate filing document. Given the lack of identifiable information and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which is the default category for filings that do not fit other specific categories.
2015-09-10 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.